Choosing the Right Therapy for Patients with Relapsed/Refractory Multiple Myeloma (RRMM) in Consideration of Patient-, Disease- and Treatment-Related Factors

Choosing the Right Therapy for Patients with Relapsed/Refractory Multiple Myeloma (RRMM) in Consideration of Patient-, Disease- and Treatment-Related Factors

Treatment of relapsed/refractory multiple myeloma (RRMM) is more complex today due to the availability of novel therapeutic options, mostly applied as combination regimens. immunotherapy options have especially increased substantially, likewise the understanding that patient-, disease- and treatment...

Full description

Bibliographic Details
Main Authors: Laura Gengenbach, Giulia Graziani, Heike Reinhardt, Amelie Rösner, Magdalena Braun, Mandy-Deborah Möller, Christine Greil, Ralph Wäsch, Monika Engelhardt
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Cancers
Subjects:
relapsed/refractory multiple myeloma (RRMM)
novel agents
immunotherapy
frailty
geriatric assessment (GA)
revised myeloma comorbidity Index (R-MCI)
Online Access:https://www.mdpi.com/2072-6694/13/17/4320

Internet

https://www.mdpi.com/2072-6694/13/17/4320

Similar Items